Allergy Thera. Regulatory News (AGY)

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Allergy Therapeutics Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Increase in total voting rights issued by the Company

 X

3. Full name of person(s) subject to the notification obligation:

FIL Limited

4. Full name of shareholder(s) (if different from 3.):

 See attached schedule

5. Date of the transaction and date on which the threshold is crossed or reached:

01 July 2009

6. Date on which issuer notified:

 03 July 2009

7. Threshold(s) that is/are crossed or reached:

10%

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Indirect

Direct

Indirect

Direct

Indirect

 GB00B02LCQ05

 8,854,410

 8,854,410

 16,343,693

 16,343,693

 6.19

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 16,343,693

 6.19

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

See attached schedule

Proxy Voting:

10. Name of the proxy holder:

 FIL Limited

11. Number of voting rights proxy holder will cease to hold:

 7,489,283

12. Date on which proxy holder will cease to hold voting rights:

 01 July 2009

13. Additional information:

 Increase in total voting rights issued by the Company

14. Contact name:

 Amanda Chana

15. Contact telephone number:

 fil-regreporting@fil.com